Log in to your Inderes Free account to see all free content on this page.
Senzime
4.51 SEK
+0.11 %
Less than 1K followers
SEZI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.11 %
-9.90 %
-16.57 %
-10.44 %
-26.75 %
-19.55 %
-38.29 %
-80.14 %
-24.09 %
Senzime operates in the medical technology industry and focuses on the development and manufacture of systems for monitoring and diagnostics in healthcare. The portfolio includes systems used to automate and measure the substances glucose and lactate in blood and tissues. The company's products are aimed at healthcare institutions and physicians. The operations are global. Senzime was founded in 1999 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
708.25M SEK
Turnover
296.6K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
22.4.
2026
Interim report Q1'26
19.5.
2026
General meeting '26
16.7.
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
Senzime launches TetraCom connectivity platform enabling universal transmission of anesthesia data
Redeye: Senzime (Q4 Initial take): Sales spot on to our estimate
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio